Bis-aminooxy-PEG1, 500mg

4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carbonitrile hydrochloride, 95.0%, 250mg

2-(Methacryloyloxy)ethyl 3-oxobutanoate (stabilised with BHT), 95.0%, 500g

tert-Butyl 6-Bromopyridin-3-ylcarbamate, 97.0%, 5g

N-(2,4-dimethoxybenzyl)-6-fluoro-N-(6-fluoropyridin-2-yl)-1H-indazole-5-sulfonamide, 95%, 1g

2,6-Di-tert-butyl-4-vinylphenol, 95.0%, 250mg

Methyl 3-methyl-4-oxotetrahydro-2H-pyran-3-carboxylate, 95.0%, 25g

ethyl (2Z)-2-chloro-2-[2-(2,5-dichlorophenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g

2-Cyano-6-methoxybenzothiazole, 98.0%, 1g

1-(2-Fluorophenyl)cyclopropanecarboxylic acid, 95.0%, 1g

Propiolic Acid>97.0%(GC)(T)5g

2-(4-Cyanophenoxy)acetic acid, 97%, 10g

2,4-Dihydroxybenzaldehyde, min. 98%, for synthesis, 100 g, glass packaging